# To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study

> **NCT00870038** · PHASE4 · UNKNOWN · sponsor: **Ospedale della Misericordia** · enrollment: 75 (estimated)

## Conditions studied

- Angioplasty, Transluminal, Percutaneous Coronary
- Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** Percutaneous coronary intervention: Paclitaxel eluting balloon (Elutax) + Genous stent
- **DEVICE:** Percutaneous coronary intervention: Uncoated balloon + Genous stent
- **DEVICE:** Percutaneous coronary intervention: Drug eluting stent (Taxus stent)

## Key facts

- **NCT ID:** NCT00870038
- **Lead sponsor:** Ospedale della Misericordia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2011-08
- **Final completion:** 2012-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2010-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870038, "To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00870038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*